Transgene appoints Antoine Beret to its Board as new Independent Director

– FRANCE, Strasbourg – Transgene (Euronext Paris:TNG), a company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases, announced the new composition of its board of directors and the appointment of new statutory auditors following yesterday’s annual shareholders’ meeting (AGM).…